These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28518529)

  • 1. SU-E-T-515: Comparison of Two Dose-Specification Methods for the Treatment of Uterine Cervix Cancer with HDR Brachytherapy Using a Tandem and Ring Applicator.
    Bhandare N; Yeung A
    Med Phys; 2012 Jun; 39(6Part18):3824. PubMed ID: 28518529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?
    Kim H; Beriwal S; Houser C; Huq MS
    Med Dosim; 2011; 36(2):166-70. PubMed ID: 20488690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of volume doses from conventional two-dimensional brachytherapy with corresponding doses from three-dimensional magnetic resonance imaging-based brachytherapy in carcinoma cervix.
    Mathews S; Azariah MB; Mohandas S; Menon SV; George P; Jayaprakash PG
    J Cancer Res Ther; 2019; 15(6):1332-1337. PubMed ID: 31898669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
    Jacob D; Lamberto M; DeSouza Lawrence L; Mourtada F
    Brachytherapy; 2017; 16(3):624-629. PubMed ID: 28365083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single line source with and without vaginal loading and the impact on target coverage and organ at risk doses for cervix cancer Stages IB, II, and IIIB: treatment planning simulation in patients treated with MRI-guided adaptive brachytherapy in a multicentre study (EMBRACE).
    Nkiwane KS; Pötter R; Tanderup K; Federico M; Lindegaard JC; Kirisits C
    Brachytherapy; 2013; 12(4):317-23. PubMed ID: 23474352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SU-E-T-430: Evaluation of Inverse Optimization in Brachytherapy for Locally Advanced Cervix Cancer.
    Liao Y; Dandekar V; Chu J; Turian J; Kiel K
    Med Phys; 2012 Jun; 39(6Part16):3803. PubMed ID: 28517217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-Fractional Variations in Volume and Radiation Dose to the Organs at Risk, High-Risk Clinical Target Volume and Implication of Image-Guided Adaptive Planning During Intracavitary Brachytherapy of Carcinoma Cervix.
    Patil G; Br KK; Narayanan G
    Cureus; 2022 Jan; 14(1):e21503. PubMed ID: 35223279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
    Beriwal S; Kim H; Heron DE; Selvaraj R
    Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sci-Sat AM: Brachy - 08: MRI-guided planning and maximum achievable HR-CTV doses in cervix brachytherapy.
    Menon G; Sloboda R; Ghosh S; Dundas G; Pearcey R; Huang F
    Med Phys; 2012 Jul; 39(7Part4):4646. PubMed ID: 28516636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commissioning and Dosimetric Results of an Indigenously Developed Intra-Vaginal Template for Interstitial Plus Intracavitary High dose Rate Image-Guided Brachytherapy of Advanced Cervix Cancer.
    Kaliyaperumal V; Banerjee S; Kataria T; Abraham SK; Kamaraj D; Tamilselvan S; Gupta D; Bisht SS; Narang K; Shishak S
    J Med Phys; 2022; 47(4):322-330. PubMed ID: 36908497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT and MR image fusion of tandem and ring applicator using rigid registration in intracavitary brachytherapy planning.
    Oinam AS; Tomar P; Patel FD; Singh L; Rai B; Bahl A
    J Appl Clin Med Phys; 2014 Mar; 15(2):4206. PubMed ID: 24710430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the IPSA Conditions to Improve the Treatment Plan Quality in Brachytherapy for Cervical Cancer.
    Yang X; Li Z; Cai Z; Tang X; Liu J; Cui S; Li M
    J Oncol; 2022; 2022():6499744. PubMed ID: 35313562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural network dose prediction for cervical brachytherapy: Overcoming data scarcity for applicator-specific models.
    Moore LC; Ahern F; Li L; Kallis K; Kisling K; Cortes KG; Nwachukwu C; Rash D; Yashar CM; Mayadev J; Zou J; Vasconcelos N; Meyers SM
    Med Phys; 2024 Jul; 51(7):4591-4606. PubMed ID: 38814165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single magnetic resonance imaging vs magnetic resonance imaging/computed tomography planning in cervical cancer brachytherapy.
    Beriwal S; Kim H; Coon D; Mogus R; Heron DE; Li X; Huq MS
    Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):483-7. PubMed ID: 19423307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints.
    Jürgenliemk-Schulz IM; Lang S; Tanderup K; de Leeuw A; Kirisits C; Lindegaard J; Petric P; Hudej R; Pötter R;
    Radiother Oncol; 2010 Mar; 94(3):339-45. PubMed ID: 19944471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric study for cervix carcinoma treatment using intensity modulated radiation therapy (IMRT) compensation based on 3D intracavitary brachytherapy technique.
    Yin G; Wang P; Lang J; Tian Y; Luo Y; Fan Z; Tam KY
    J Contemp Brachytherapy; 2016 Jun; 8(3):221-32. PubMed ID: 27504132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
    Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
    Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of impact of target delineation of computed tomography- and magnetic resonance imaging-guided brachytherapy on dose distribution in cervical cancer.
    Tuntipumiamorn L; Lohasammakul S; Dankulchai P; Nakkrasae P
    J Contemp Brachytherapy; 2018 Oct; 10(5):418-424. PubMed ID: 30479618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SU-E-T-426: Comparison of HDR Brachytherapy for Cervix Cancer Using an Adaptive Simulated Annealing Program and Oncentra- for Simultaneously Integrated Boost.
    Yao R; Liao Y; Kiel K; Templeton A; Turian J; Chu J
    Med Phys; 2012 Jun; 39(6Part16):3802-3803. PubMed ID: 28517211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.